Suppr超能文献

钙化防御的多因素发病机制:1 例报告。

The Multifactorial Pathogenesis of Calciphylaxis: A Case Report.

机构信息

Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland.

出版信息

Am J Case Rep. 2021 Jun 7;22:e930026. doi: 10.12659/AJCR.930026.

Abstract

BACKGROUND Calciphylaxis is a rare and lifethreatening syndrome characterized by small vascular calcifications, which lead to the occlusion of blood vessels and painful skin lesions with tissue necrosis. Although the disease can develop in a population without kidney failure, it is typically detected in patients receiving dialysis, with an increasing frequency ranging from 1% to 4%. Therefore, the disease is also known as calcific uremic arteriolopathy. The prognosis in patients with coexisting chronic kidney disease is very poor, with a 1-year mortality rate of up to 80%. Numerous risk factors for calciphylaxis have been described, such as obesity, diabetes mellitus, female sex, White race, overuse of calcium and vitamin D supplements, and vitamin K deficiency. The disease is often accompanied by disorders such as hyperphosphatemia, elevated parathyroid hormone level, and a deficiency of natural calcification inhibitors, such as fetuin-A and matrix Gla protein. However, not all patients with calciphylaxis have the abnormalities described above, suggesting that the pathogenesis of calciphylaxis is multifactorial and unfortunately still uncertain. CASE REPORT We report a case of calciphylaxis in a 52-year-old White woman with multiple comorbidities and on chronic hemodialysis treatment, who presented with severe subcutaneous painful nodules and necrotic ulcers on both legs. CONCLUSIONS Although the prognosis of this rare and underrecognized disease is poor, an early diagnosis and interdisciplinary treatment including pain relief, wound care, appropriate nutritional support, correction of mineral parameters, administration of sodium thiosulphate, and adequate hemodialysis therapy can improve patient quality of life.

摘要

背景

钙化防御是一种罕见且危及生命的综合征,其特征为小血管钙化,导致血管阻塞和伴有组织坏死的疼痛性皮肤损伤。尽管该疾病可在无肾衰竭的人群中发生,但通常在接受透析的患者中检测到,其发生率从 1%到 4%不等。因此,该疾病也称为钙化尿毒症性小动脉病。同时患有慢性肾脏病的患者预后非常差,1 年死亡率高达 80%。钙化防御有许多已知的危险因素,如肥胖、糖尿病、女性、白种人、钙和维生素 D 补充剂过量以及维生素 K 缺乏。该疾病常伴有高磷血症、甲状旁腺激素水平升高以及天然钙化抑制剂(如胎球蛋白-A 和基质 Gla 蛋白)缺乏等紊乱。然而,并非所有钙化防御患者都有上述异常,这表明钙化防御的发病机制是多因素的,不幸的是目前仍不清楚。病例报告:我们报告了一例 52 岁白人女性钙化防御病例,该患者患有多种合并症且正在接受慢性血液透析治疗,其双侧下肢出现严重的皮下疼痛性结节和坏死性溃疡。结论:尽管这种罕见且认识不足的疾病预后较差,但早期诊断和多学科治疗(包括缓解疼痛、伤口护理、适当的营养支持、纠正矿物质参数、硫代硫酸钠给药以及充分的血液透析治疗)可提高患者的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1f8/8197444/31a436a9c5e1/amjcaserep-22-e930026-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验